Literature DB >> 15012850

Stroop performance in drug users classified by HIV and hepatitis C virus serostatus.

Eileen M Martin, Richard M Novak, Michael Fendrich, Jasmin Vassileva, Raul Gonzalez, Silvana Grbesic, Gerald Nunnally, Lisa Sworowski.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15012850     DOI： 10.1017/S135561770410218X

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN： 1355-6177            Impact factor:   2.892


× No keyword cloud information.
  34 in total

Review 1.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk.

Authors:  Erin E Morgan; Steven Paul Woods; Alexandra Rooney; William Perry; Igor Grant; Scott L Letendre
Journal:  Clin Neuropsychol       Date:  2012-04-26       Impact factor: 3.535

3.  Are all drug addicts impulsive? Effects of antisociality and extent of multidrug use on cognitive and motor impulsivity.

Authors:  Jasmin Vassileva; Raul Gonzalez; Antoine Bechara; Eileen M Martin
Journal:  Addict Behav       Date:  2007-04-19       Impact factor: 3.913

Review 4.  Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction.

Authors:  Laura L Giacometti; Jacqueline M Barker
Journal:  Brain Res       Date:  2019-08-14       Impact factor: 3.252

5.  Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task.

Authors:  Christina S Meade; Ryan P Bell; Sheri L Towe; Nan-Kuei Chen; Andrea L Hobkirk; Scott A Huettel
Journal:  Addict Biol       Date:  2018-09-21       Impact factor: 4.280

Review 6.  Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action.

Authors:  Erica Weber; Kaitlin Blackstone; Steven Paul Woods
Journal:  Neuropsychol Rev       Date:  2013-02-16       Impact factor: 7.444

7.  The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals.

Authors:  Sapna M Patel; April D Thames; Natalie Arbid; Stella E Panos; Steven Castellon; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2013-04-03       Impact factor: 2.475

8.  Iowa Gambling Task performance and emotional distress interact to predict risky sexual behavior in individuals with dual substance and HIV diagnoses.

Authors:  Margaret C Wardle; Raul Gonzalez; Antoine Bechara; Eileen M Martin-Thormeyer
Journal:  J Clin Exp Neuropsychol       Date:  2010-05-17       Impact factor: 2.475

9.  Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin.

Authors:  Theodore R Miller; Jeffrey J Weiss; Norbert Bräu; Douglas T Dieterich; Alicia Stivala; Monica Rivera-Mindt
Journal:  J Neurovirol       Date:  2016-11-28       Impact factor: 2.643

10.  Improvements in brain and behavior following eradication of hepatitis C.

Authors:  Taylor Kuhn; Philip Sayegh; Jacob D Jones; Jason Smith; Manoj K Sarma; A Ragin; Elyse J Singer; M Albert Thomas; April D Thames; Steven A Castellon; Charles H Hinkin
Journal:  J Neurovirol       Date:  2017-05-30       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.